Abivax SA American Depositary Shares (ABVX) is a publicly traded Healthcare sector company. As of October 9, 2026, ABVX trades at $87.96 with a market cap of $7.59B and a P/E ratio of 0.00. ABVX moved -1.34% today. Year to date, ABVX is -33.43%; over the trailing twelve months it is +2.94%. Its 52-week range spans $4.77 to $148.83. Analyst consensus is strong buy with an average price target of $158.75. Rallies surfaces ABVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ABVX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $87.96 |
| Market Cap | $7.59B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $148.83 |
| 52-Week Low | $4.77 |
| Volume | 420.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover ABVX: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $158.75.